This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C₁₇H₂₀F₂N₄O₃S

Abstract

C17H 20 F 2 N4O 3 S, triclinic, P1 (no. 1), a = 6.0020(12) Å, CCDC no.: 1463122Tables 1-3 contain details of the methods used and a list of the atoms including atomic coordinates and displacement parameters.